Task: Answer the following question about the molecule with SMILES CCCCCc1cccc(CC(=O)O)c1.
Description: Please describe this drug.
Answer: Setogepram is under investigation in clinical trial NCT03184584 (Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome).
Task: Answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CCCCCc1cccc(CC(=O)O)c1
CCCCCC1=CC(=CC=C1)CC(=O)O
2-(3-pentylphenyl)acetic acid
Please describe this drug.